Healthcare & Life Sciences News and Articles

Google News – CDC External News

CDC Updates Mpox Vaccine Guidance as Clade I Threat Expands Globally - Global Biodefense

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals - STAT

news.google.com · 09 Sep 2026

Google News – Biopharma External News

How Novartis' Double-Stacked Failures Shook Biotech - Investor's Business Daily

news.google.com · 09 Sep 2026

Industry News External News

“I’m no longer afraid to go to hospital”: bringing healthcare to cocoa farmers in Côte d’Ivoire - Gavi, the Vaccine Alliance

news.google.com · 08 Sep 2026

Google News – Biopharma External News

AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD - Fierce Biotech

news.google.com · 08 Sep 2026

Google News – Biopharma External News

SC's Emerging Biotech Industry Receives National Recognition - Greenville Business Magazine

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer - Fierce Pharma

news.google.com · 08 Sep 2026

Google News – Oncology External News

Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability - Fierce Biotech

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA withdraws Krazati's colorectal cancer indication after confirmatory trial miss - The Pharma Letter

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA approves AstraZeneca breast cancer drug - STAT

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform - Stocktwits

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Pharvaris' latest phase 3 win builds case for HAE drug with FDA verdict pending - Fierce Biotech

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform - TradingView

news.google.com · 08 Sep 2026

Google News – Biotech Funding External News

The pursuit of quick returns threatens “groundbreaking” research: Have biotech investors become bankers? - medwatch.com

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter

news.google.com · 08 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

CDC Updates Mpox Vaccine Guidance as Clade I Threat Expands Globally - Global Biodefense

FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals - STAT

How Novartis' Double-Stacked Failures Shook Biotech - Investor's Business Daily

“I’m no longer afraid to go to hospital”: bringing healthcare to cocoa farmers in Côte d’Ivoire - Gavi, the Vaccine Alliance

AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD - Fierce Biotech

SC's Emerging Biotech Industry Receives National Recognition - Greenville Business Magazine

FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer - Fierce Pharma

Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability - Fierce Biotech

FDA withdraws Krazati's colorectal cancer indication after confirmatory trial miss - The Pharma Letter

FDA approves AstraZeneca breast cancer drug - STAT

Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform - Stocktwits

Pharvaris' latest phase 3 win builds case for HAE drug with FDA verdict pending - Fierce Biotech

Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform - TradingView

The pursuit of quick returns threatens “groundbreaking” research: Have biotech investors become bankers? - medwatch.com

Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter